Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to fall 30.43% to -15 cents per share on May 08

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q1'25

Est.

$-0.16

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.12

Q1'24

Missed

by $0.52

The last earnings report on March 20 showed earnings per share of -23 cents, beating the estimate of -28 cents. With 7.03K shares outstanding, the current market capitalization sits at 44.51M.

View a ticker or compare two or three

Compare

ARMP